职业培训景气回升

Search documents
海外消费周报:2025下半年港股消费服务投资策略:关注茶饮新股,把握出行链机会-20250606
Shenwan Hongyuan Securities· 2025-06-06 11:42
Group 1: Hong Kong Consumer Services Investment Strategy - The report highlights the significant effect of the ready-to-drink tea segment, emphasizing the competition in supply chains. Mixue has the largest and earliest established supply chain, while Gu Ming excels in fruit procurement and cold chain logistics. Both companies are expected to enter the Hong Kong Stock Connect on June 9 [1][4]. - Online travel competition in China is improving, with Tongcheng Travel showing high performance and expected profit margin improvements. Trip.com Group's short-term investments may impact profit margins, but long-term growth is anticipated [1][4]. - Macau's gaming revenue shows resilience, with May gross gaming revenue reaching 21.2 billion MOP, a post-pandemic high, reflecting a 5% year-on-year increase and recovering 82% compared to the same period in 2019 [1][4]. Group 2: Key Companies to Watch - Key companies to focus on include Gu Ming (01364.HK), Mixue Group (02097.HK), Trip.com Group (09961.HK), and MGM China (02282.HK) [1][5]. Group 3: Overseas Pharmaceutical Developments - The report notes that the Hang Seng Healthcare Index rose by 2.35%, outperforming the Hang Seng Index by 0.93 percentage points [7]. - Domestic pharmaceutical companies are making progress, with Hansoh granting Regeneron global exclusive rights to its GLP-1/GIP dual receptor agonist HS-20094, receiving an upfront payment of $80 million and potential milestone payments of up to $1.93 billion [9][10]. - BioNTech and BMS have reached an agreement to co-develop and commercialize BioNTech's dual-specific antibody BNT327, with BMS paying an upfront fee of $1.5 billion and potential milestone payments of up to $7.6 billion [10]. Group 4: Education Sector Insights - The education index increased by 2.2%, outperforming the Hang Seng China Enterprises Index by 0.4 percentage points, with a year-to-date increase of 8.76% [14]. - The report suggests focusing on Hong Kong higher education companies, anticipating improved profitability due to slowed investment and peak capital expenditures. Recommended companies include Yuhua Education, Neusoft Ruixin Group, and China Education Group [16]. - The report also highlights the recovery in vocational training demand, with a positive outlook for China Oriental Education, which is expected to significantly enhance operational efficiency [16].
海外消费周报:三生制药与辉瑞就SSGJ-707(PD-1/VEGF双抗)达成重磅合作,首付款超10亿美金-20250523
Shenwan Hongyuan Securities· 2025-05-23 12:15
Investment Rating - The report maintains an "Overweight" rating for the overseas pharmaceutical industry, indicating a positive outlook for the sector [3][6]. Core Insights - A significant collaboration has been established between Sanofi and Pfizer regarding SSGJ-707 (PD-1/VEGF dual antibody), with an upfront payment exceeding $1.25 billion and potential total payments reaching $4.8 billion, including milestone payments and a double-digit percentage sales share [3][7]. - The Hang Seng Healthcare Index increased by 6.83%, outperforming the Hang Seng Index by 6.44 percentage points [6]. Summary by Sections 1. Overseas Pharmaceuticals - Sanofi and Pfizer's collaboration on SSGJ-707 includes global development rights, with Sanofi receiving an upfront payment of $1.25 billion and potential total payments of up to $4.8 billion [3][7]. - Kelun Biotech's TROP2 ADC has received acceptance for a new indication application, targeting HR+ HER2- breast cancer patients [3][7]. - Innovent Biologics' CD19 monoclonal antibody has been approved for the treatment of relapsed/refractory diffuse large B-cell lymphoma in China [3][7]. - The report highlights the approval of BMS's TYK2 inhibitor for a new indication and a collaboration between Roche and Orionis for small molecule drugs [4][8]. 2. Overseas Social Services - Ctrip's Q1 2025 revenue increased by 16% to 13.9 billion yuan, with a non-GAAP operating profit of 4 billion yuan, maintaining a profit margin of 29% [12]. - The report maintains a target price of 590 HKD for Ctrip, with a "Buy" rating [12]. 3. Overseas Education - The education index rose by 1.4%, outperforming the Hang Seng National Enterprises Index by 0.7 percentage points [16]. - The report suggests focusing on vocational education companies, particularly China Oriental Education, due to a rebound in training demand [18].